137 related articles for article (PubMed ID: 22586144)
1. Molecular pathology and genetics of pancreatic endocrine tumours.
Capurso G; Festa S; Valente R; Piciucchi M; Panzuto F; Jensen RT; Delle Fave G
J Mol Endocrinol; 2012 Aug; 49(1):R37-50. PubMed ID: 22586144
[TBL] [Abstract][Full Text] [Related]
2. Well-differentiated pancreatic neuroendocrine carcinoma in tuberous sclerosis--case report and review of the literature.
Arva NC; Pappas JG; Bhatla T; Raetz EA; Macari M; Ginsburg HB; Hajdu CH
Am J Surg Pathol; 2012 Jan; 36(1):149-53. PubMed ID: 22173120
[TBL] [Abstract][Full Text] [Related]
3. RASSF1A promoter methylation and 3p21.3 loss of heterozygosity are features of foregut, but not midgut and hindgut, malignant endocrine tumours.
Pizzi S; Azzoni C; Bottarelli L; Campanini N; D'Adda T; Pasquali C; Rossi G; Rindi G; Bordi C
J Pathol; 2005 Aug; 206(4):409-16. PubMed ID: 15887288
[TBL] [Abstract][Full Text] [Related]
4. Cyclin-dependent kinase 4 (CDK4) expression in pancreatic endocrine tumors.
Lindberg D; Hessman O; Akerström G; Westin G
Neuroendocrinology; 2007; 86(2):112-8. PubMed ID: 17664862
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
[TBL] [Abstract][Full Text] [Related]
6. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA
Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583
[TBL] [Abstract][Full Text] [Related]
7. [Hereditary tumours of the endocrine pancreas].
Igaz P; Igaz I; Rácz K; Tulassay Z
Orv Hetil; 2006 Feb; 147(5):195-200. PubMed ID: 16509219
[TBL] [Abstract][Full Text] [Related]
8. Endocrine tumours of the gastrointestinal tract: aetiology, molecular pathogenesis and genetics.
Rindi G; Bordi C
Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):519-34. PubMed ID: 16183525
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia.
Biankin AV; Kench JG; Morey AL; Lee CS; Biankin SA; Head DR; Hugh TB; Henshall SM; Sutherland RL
Cancer Res; 2001 Dec; 61(24):8830-7. PubMed ID: 11751405
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of CDKN2C/p18, CDKN1B/p27 and CDKN2B/p15 mRNA expression, and CpG methylation status in sporadic and MEN1-associated pancreatic endocrine tumours.
Lindberg D; Akerström G; Westin G
Clin Endocrinol (Oxf); 2008 Feb; 68(2):271-7. PubMed ID: 17803708
[TBL] [Abstract][Full Text] [Related]
11. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
Kley N; Whaley J; Seizinger BR
Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
[TBL] [Abstract][Full Text] [Related]
12. Hereditary pancreatic endocrine tumours.
Alexakis N; Connor S; Ghaneh P; Lombard M; Smart HL; Evans J; Hughes M; Garvey CJ; Vora J; Vinjamuri S; Sutton R; Neoptolemos JP
Pancreatology; 2004; 4(5):417-33; discussion 434-5. PubMed ID: 15249710
[TBL] [Abstract][Full Text] [Related]
13. Duodenal carcinoid tumours, phaeochromocytoma and neurofibromatosis: islet cell tumour, phaeochromocytoma and the von Hippel-Lindau complex: two distinctive neuroendocrine syndromes.
Griffiths DF; Williams GT; Williams ED
Q J Med; 1987 Sep; 64(245):769-82. PubMed ID: 2897130
[TBL] [Abstract][Full Text] [Related]
14. Molecular control of the cell cycle in cancer: biological and clinical aspects.
Møller MB
Dan Med Bull; 2003 May; 50(2):118-38. PubMed ID: 12812137
[TBL] [Abstract][Full Text] [Related]
15. Mutational analyses of WNT7A and HDAC11 as candidate tumour suppressor genes in sporadic malignant pancreatic endocrine tumours.
Lindberg D; Akerström G; Westin G
Clin Endocrinol (Oxf); 2007 Jan; 66(1):110-4. PubMed ID: 17201809
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic neuroendocrine neoplasms: Updates on genomic changes in inherited tumour syndromes and sporadic tumours based on WHO classification.
Ishida H; Lam AK
Crit Rev Oncol Hematol; 2022 Apr; 172():103648. PubMed ID: 35248713
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetics of neuroendocrine tumors.
Duerr EM; Chung DC
Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):1-14. PubMed ID: 17382262
[TBL] [Abstract][Full Text] [Related]
18. [Associated gastroenteropancreatic neuroendocrine tumours to familiar syndromes].
Lecumberri Pascual E
Endocrinol Nutr; 2009 Apr; 56 Suppl 2():10-5. PubMed ID: 19627764
[TBL] [Abstract][Full Text] [Related]
19. [Genetics of neuroendocrine tumours, hereditary tumour syndromes].
Igaz P
Orv Hetil; 2013 Sep; 154(39):1541-8. PubMed ID: 24058099
[TBL] [Abstract][Full Text] [Related]
20. Genetics of Pancreatic Neuroendocrine Tumors.
Mohindroo C; McAllister F; De Jesus-Acosta A
Hematol Oncol Clin North Am; 2022 Oct; 36(5):1033-1051. PubMed ID: 36154786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
